A potential breakthrough in treating late-stage ovarian cancer has come from researchers who have discovered a peptide that shrinks advanced tumors and improves survival rates for this deadly but often undetected disease.
A potential breakthrough in treating late-stage ovarian cancer has come from researchers who have discovered a peptide that shrinks advanced tumors and improves survival rates for this deadly but often undetected disease.